Stockreport

Maravai LifeSciences Holdings, Inc. (MRVI) Admits to Incorrect Revenue Recognition, Ineffective Internal Controls; Class Action Pending – Hagens Berman

Maravai LifeSciences Holdings, Inc. - Class A common stock  (MRVI) 
PDF SAN FRANCISCO, March 28, 2025 (GLOBE NEWSWIRE) -- On Mar. 19, 2025, the price of Maravai LifeSciences (NASDAQ: MRVI) shares fell almost 6% after the company warned inv [Read more]